By Jeff Overley ( July 17, 2015, 4:37 PM EDT) -- A group of lawmakers, generic-drug industry advocates and public health experts on Friday denounced proposals in the Trans-Pacific Partnership to strengthen exclusivity protections for brand-name biologics, warning that the provisions would seriously harm access to affordable copycat medicines....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.